The latest announcement! 173 pharmaceutical companies net profit ranking

Medical News, October 30 hearing Into late October, most pharmaceutical companies have been published in the third quarter newspaper.

According to Cypriot Blue incomplete statistics, as of 30, there are 173 pharmaceutical companies released third quarter newspaper from the published data point of view, the average growth rate of pharmaceutical companies reached 96.9%, the overall growth rate is good.

From the big environment, the pharmaceutical industry began to enter a long cycle of a new starting point, after experiencing the growth rate of the pharmaceutical industry in 2015, under the influence of the relevant policies, the pharmaceutical industry gradually recovered to pick up a number of analysts believe that the pharmaceutical sector to pick up the momentum Strong, and sustainable.

Some experts pointed out that the pharmaceutical industry is a policy impact is much higher than other areas of the industry.On the last day of the National Day holiday, the two issued the "review on the deepening of the review system to encourage the reform drug medical instruments Innovative ideas ", the pharmaceutical innovation made a big red envelope, coupled with the recently released"Drug registration Management approach (revised draft) "in turn the new drug data protection, policy environment significantly better.

From 173 medicine enterprise The third quarter report data, performance year on year last year, the vast majority of growth is very gratifying, and some even a substantial increase.

For example, Livzon Group, its third quarter net profit of 4.246 billion yuan, an increase of 590.7%. Chengzhi shares third quarter net profit of 670 million yuan, an increase of 2972%. Zhi Fei biological third quarter net profit of 113 million, An increase of 2249.55%.

Today, the pharmaceutical industry, especially pharmaceutical companies increasingly fierce competition, performance growth of enterprises, naturally there will be performance decline in the enterprise.

For example, Tai Chi Group, its third quarter net profit of 78 million, down 91.59%. Hai Purui third quarter net profit of 52.6 million, down 82.7%. North China Pharmaceutical third quarter net profit of 21.7 million, down 66.47%.

In recent years, the pharmaceutical industry policy warm wind blowing, timely analysis of the policy, timely grasp of the dividend is the pharmaceutical companies must pay attention to the distance from the end of 2017 only two months time, I believe the major pharmaceutical companies will seize the opportunity in the fourth Quarter to achieve the final counterattack in the fierce competition, the pharmaceutical companies in 2017 will be how to pay a surprising answer? Let us look forward to.